American Patients First Act of 2026
Key claim: The American Patients First Act of 2026 (HR9972) was introduced in the 119th Congress and referred to the House Committees on Energy and Commerce and Ways and Means.
Abstract
(HR9972 · 119th Congress) Latest action (2026-07-27): Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Why this matters
The American Patients First Act of 2026 revives branding associated with earlier federal drug-pricing blueprints, signaling continued congressional interest in prescription cost policy. At the referral stage with no public text, the practical impact on what patients pay or what plans cover remains undetermined, but the bill’s dual referral to Energy and Commerce and Ways and Means indicates a scope touching both Public Health Service Act and Medicare/tax-jurisdiction levers.